Financing

Repayments of Short-Term Debt

Pfizer Repayments of Short-Term Debt decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $2.05B to $0.00.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

High repayment levels indicate the firm is successfully deleveraging or rolling over short-term obligations.

Detailed definition

This represents cash outflows used to settle short-term debt obligations, including commercial paper and other borrowing...

Peer comparison

Standard for all firms with active treasury management; should be viewed alongside issuance levels.

Metric ID: financing_repayments_of_short_term_debt

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q1 '26
Value$0.00$1.00M-$1.00M$971.75M$971.75M$971.75M$971.75M$0.00$0.00$0.00$3.00M$328.00M$4.52B$2.92B$3.45B$2.05B$151.00M$0.00
QoQ Change-200.0%>999%+0.0%+0.0%+0.0%-100.0%>999%>999%-35.4%+18.1%-40.7%-92.6%-100.0%
YoY Change>999%>999%-100.0%-100.0%-100.0%-99.7%>999%+524.4%-96.7%-100.0%
Range-$1.00M$4.52B
Avg YoY Growth>999%
Median YoY Growth-98.2%
Current Streak3 quarters decline

Repayments of Short-Term Debt at Other Companies

Frequently Asked Questions

What is Pfizer's repayments of short-term debt?
Pfizer (PFE) reported repayments of short-term debt of $0.00 in Q1 2026.
How has Pfizer's repayments of short-term debt changed year-over-year?
Pfizer's repayments of short-term debt decreased by 100.0% year-over-year, from $2.05B to $0.00.
What does repayments of short-term debt mean?
Cash paid to settle debt obligations that were due within one year.